Skip to main content

Pulse Biosciences, Inc.

PLSE
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001625101

In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Pulse Biosciences, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of PLSE: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders6157−4
Shares4.76M4.83M+74.1K (+1.6%)
Value$41.4M$54.1M+$12.6M (+30.5%)

New holders (8)

Institutions that held Pulse Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to PLSE in Q2 2024
InstitutionSharesValue% of portfolio
Alliancebernstein L.P.11,820$132.3K0.00%
Yakira Capital Management, Inc.11,313$126.6K0.05%
Mirae Asset Global ETFs Holdings Ltd.10,910$122.1K0.00%
Invesco Ltd.10,811$121.0K0.00%
Creative Planning10,243$114.6K0.00%
Corebridge Financial, Inc.9,850$110.2K0.00%
Quest Partners LLC8,134$91.0K0.01%
SRS Capital Advisors, Inc.244$2.73K0.00%

Sold out (12)

Institutions that held Pulse Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.